Pfm Health Sciences, LP Syndax Pharmaceuticals Inc Transaction History

Pfm Health Sciences, LP

$1.71 Billion
Q3 2024

A detailed history of Pfm Health Sciences, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Pfm Health Sciences, LP holds 423,910 shares of SNDX stock, worth $5.56 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

423,910

Previous 387,357 9.44%

Holding current value

$5.56 Million

Previous $7.95 Million 2.62%

% of portfolio

0.48%

Previous 0.41%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $655,395 - $906,879	36,553 Added 9.44%	423,910 $8.16 Million
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $5.11 Million - $6.46 Million	-271,337 Reduced 41.19%	387,357 $7.95 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $1.25 Million - $1.55 Million	63,171 Added 10.61%	658,694 $15.7 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $24.1 Million - $45.9 Million	-2,119,712 Reduced 78.07%	595,523 $12.9 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $7.88 Million - $11.8 Million	542,798 Added 24.99%	2,715,235 $39.4 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $4.37 Million - $5.04 Million	225,785 Added 11.6%	2,172,437 $45.5 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $2.73 Million - $3.83 Million	132,018 Added 7.28%	1,946,652 $41.1 Million
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $10.8 Million - $13.8 Million	525,561 Added 40.77%	1,814,634 $46.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $13.1 Million - $17.6 Million	708,305 Added 121.96%	1,289,073 $31 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $19.9 Million - $28.5 Million	-1,462,609 Reduced 71.58%	580,768 $11.2 Million
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $892,403 - $1.33 Million	-60,135 Reduced 2.86%	2,043,377 $35.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $3.76 Million - $5.55 Million	246,774 Added 13.29%	2,103,512 $46 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $4 Million - $5.71 Million	-288,143 Reduced 13.43%	1,856,738 $35.5 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $8.87 Million - $16.6 Million	660,654 Added 44.51%	2,144,881 $36.8 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $28.6 Million - $36.5 Million	1,484,227 New	1,484,227 $33.2 Million

Others Institutions Holding SNDX

# of Institutions

229

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $742M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account

Pfm Health Sciences, LP Syndax Pharmaceuticals Inc Transaction History